ALK inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ALK inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis

Published:2020-02-19 Issue:2 Volume:15 Page:e0229179
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Elliott Jesse^ORCID,Bai Zemin,Hsieh Shu-Ching,Kelly Shannon E.,Chen Li,Skidmore Becky,Yousef Said,Zheng Carine,Stewart David J.,Wells George A.

Funder

Canadian Institutes of Health Research

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference53 articles.

1. Cancer statistics, 2017;RL Siegel;CA Cancer J Clin,2017

2. Society CC. Lung cancer statistics 2017 [cited 2018 August 3]. http://www.cancer.ca/en/cancer-information/cancer-type/lung/statistics/?region=pe.

3. A genomics-based classification of human lung tumors;Science translational medicine,2013

4. Current Molecular-Targeted Therapies in NSCLC and Their Mechanism of Resistance;Z Schrank;Cancers,2018

5. Alectinib versus crizotinib in untreated ALK-positive non-small-cell lung cancer;S Peters;The New England journal of medicine,2017

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimating the replicability of highly cited clinical research (2004–2018);PLOS ONE;2024-08-07

2. The safety and efficacy of binimetinib for lung cancer: a systematic review;BMC Pulmonary Medicine;2024-08-01

3. Role and Function of Receptor Tyrosine Kinases in BRAF Mutant Cancers;Receptors;2024-03-04

4. Cardiovascular disease and lung cancer;Frontiers in Oncology;2024-02-12

5. Identifying optimal ALK inhibitors in first- and second-line treatment of patients with advanced ALK-positive non-small-cell lung cancer: a systematic review and network meta-analysis;BMC Cancer;2024-02-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3